IDEXX LABORATORIES INC /DE (IDXX) Current Ratio
- Current ratio · latest quarter: Value 1.17×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.17× | Current assets / current liabilities. $1.51B ÷ $1.29B ≈ 1.17× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 1.51B USD | Assets, Current |
| Current obligations | 1.29B USD | Liabilities, Current |
| Cash and equivalents | 196.93M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Debt Securities, Available-for-sale, Current |
| Customer receivables | 627.08M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 391.58M USD | Inventory, Net |
| Payables | 129.10M USD | Accounts Payable, Current |
| Borrowing debt due within one year | 150.00M USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.51B | $1.29B | $196.93M | (m) | $627.08M | $391.58M | $129.10M | $150.00M | 1.17× |
| 2026-03-31 | $1.45B | $1.30B | $200.53M | (m) | $603.54M | $382.40M | $129.97M | $150.00M | 1.12× |
| 2025-12-31 | $1.41B | $1.15B | $180.07M | (m) | $552.38M | $377.76M | $110.41M | $75.00M | 1.23× |
| 2025-09-30 | $1.48B | $1.25B | $208.17M | (m) | $566.88M | $391.56M | $122.27M | $150.00M | 1.18× |
| 2025-06-30 | $1.36B | $1.22B | $164.59M | (m) | $560.56M | $392.58M | $116.58M | $74.99M | 1.11× |
| 2025-03-31 | $1.32B | $1.14B | $163.97M | (m) | $527.46M | $395.99M | $120.10M | $170.93M | 1.16× |
| 2024-12-31 | $1.40B | $1.07B | $288.27M | (m) | $473.57M | $381.88M | $114.21M | $167.79M | 1.31× |
| 2024-09-30 | $1.43B | $1.01B | $308.64M | (m) | $511.25M | $389.80M | $110.60M | $99.14M | 1.42× |
| 2024-06-30 | $1.53B | $1.12B | $401.59M | (m) | $533.61M | $379.96M | $117.47M | $170.11M | 1.37× |
| 2024-03-31 | $1.50B | $956.90M | $397.43M | (m) | $507.21M | $390.60M | $117.46M | $75.00M | 1.57× |
| 2023-12-31 | $1.50B | $951.55M | $453.93M | (m) | $457.44M | $380.28M | $110.64M | $75.00M | 1.57× |
| 2023-09-30 | $1.38B | $970.19M | $331.70M | (m) | $452.70M | $393.97M | $112.61M | $149.99M | 1.43× |
| 2023-06-30 | $1.18B | $883.86M | $132.84M | (m) | $461.86M | $395.14M | $107.66M | $74.99M | 1.33× |
| 2023-03-31 | $1.15B | $1.07B | $111.37M | (m) | $446.02M | $391.01M | $117.71M | $74.99M | 1.08× |
| 2022-12-31 | $1.10B | $1.24B | $112.55M | (m) | $400.62M | $367.82M | $110.22M | $74.98M | 0.89× |
| 2022-09-30 | $1.06B | $1.19B | $99.18M | (m) | $388.07M | $354.98M | $110.14M | $0.00 | 0.89× |
| 2022-06-30 | $1.04B | $1.17B | $114.36M | (m) | $412.90M | $332.56M | $127.26M | $0.00 | 0.89× |
| 2022-03-31 | $1.09B | $971.34M | $204.62M | (m) | $402.24M | $301.64M | $120.88M | $0.00 | 1.12× |
| 2021-12-31 | $955.65M | $763.58M | $144.45M | (m) | $368.35M | $269.03M | $116.14M | $75.00M | 1.25× |
| 2021-09-30 | $938.04M | $633.85M | $145.20M | (m) | $376.76M | $258.48M | $86.68M | $74.99M | 1.48× |
| 2021-06-30 | $1.00B | $651.81M | $232.13M | (m) | $382.31M | $241.39M | $93.02M | $124.98M | 1.54× |
| 2021-03-31 | $1.10B | $620.66M | $351.16M | (m) | $381.79M | $225.56M | $87.17M | $124.97M | 1.77× |
| 2020-12-31 | $1.06B | $582.76M | $383.93M | (m) | $331.43M | $209.87M | $74.56M | $49.99M | 1.82× |
| 2020-09-30 | $868.68M | $526.84M | $175.59M | (m) | $337.59M | $217.60M | $71.93M | $49.98M | 1.65× |
| 2020-06-30 | $779.61M | $540.58M | $105.29M | (m) | $320.32M | $229.38M | $73.90M | (m) | 1.44× |
| 2020-03-31 | $721.35M | $846.24M | $81.39M | (m) | $299.98M | $211.64M | $74.21M | (m) | 0.85× |
| 2019-12-31 | $679.64M | $725.34M | $90.33M | (m) | $269.31M | $195.02M | $72.17M | $0.00 | 0.94× |
| 2019-09-30 | $703.38M | $626.63M | $104.00M | (m) | $268.32M | $204.89M | $75.52M | (m) | 1.12× |
| 2019-06-30 | $712.30M | $618.91M | $110.84M | (m) | $286.15M | $196.88M | $67.61M | (m) | 1.15× |
| 2019-03-31 | $697.65M | $689.62M | $116.62M | (m) | $281.16M | $189.47M | $70.14M | (m) | 1.01× |
| 2019-01-01 | $653.18M | $784.22M | (m) | (m) | (m) | (m) | (m) | (m) | 0.83× |
| 2018-12-31 | $654.17M | $770.44M | $123.79M | (m) | $248.85M | $173.30M | $69.53M | (m) | 0.85× |
| 2018-09-30 | $704.20M | $759.54M | $146.88M | $0.00 | $264.56M | $179.68M | $65.46M | (m) | 0.93× |
| 2018-06-30 | $739.83M | $774.32M | $174.56M | $0.00 | $265.01M | $176.49M | $68.02M | (m) | 0.96× |
| 2018-03-31 | $701.71M | $728.84M | $159.23M | (m) | $259.87M | $179.04M | $70.41M | (m) | 0.96× |
| 2017-12-31 | $971.99M | $1.00B | $187.68M | $284.25M | $234.60M | $164.32M | $66.97M | (m) | 0.97× |
| 2017-09-30 | $942.72M | $996.54M | $169.02M | $285.08M | $228.16M | $176.75M | $60.58M | (m) | 0.95× |
| 2017-06-30 | $918.66M | $1.00B | $165.97M | $256.92M | $240.26M | $169.69M | $58.61M | (m) | 0.92× |
| 2017-03-31 | $878.59M | $936.08M | $160.41M | $239.93M | $225.35M | $172.18M | $62.25M | (m) | 0.94× |
| 2016-12-31 | $845.58M | $934.57M | $154.90M | $236.95M | $204.49M | $158.03M | $60.06M | (m) | 0.90× |
| 2016-09-30 | $828.10M | $760.21M | $150.07M | $241.40M | $204.70M | $168.47M | $44.13M | (m) | 1.09× |
| 2016-06-30 | $821.11M | $822.78M | $141.14M | $229.06M | $212.23M | $175.69M | $50.09M | (m) | 1.00× |
| 2016-03-31 | $809.01M | $878.67M | $132.95M | $217.62M | $212.07M | $183.76M | $52.46M | (m) | 0.92× |
| 2015-12-31 | $821.63M | $856.76M | $128.99M | $213.59M | $188.32M | $188.83M | $52.65M | (m) | 0.96× |
| 2015-09-30 | $833.40M | $824.77M | $141.15M | $208.40M | $190.90M | $192.41M | $53.61M | (m) | 1.01× |
| 2015-06-30 | $833.03M | $775.43M | $163.15M | $180.87M | $199.44M | $184.50M | $58.21M | (m) | 1.07× |
| 2015-03-31 | $808.91M | $803.45M | $182.16M | $139.22M | $196.23M | $173.37M | $44.18M | (m) | 1.01× |
| 2014-12-31 | $759.40M | $820.91M | $322.54M | (m) | $152.38M | $160.34M | $44.74M | (m) | 0.93× |
| 2014-09-30 | $702.62M | $630.26M | $292.74M | (m) | $160.47M | $156.01M | $58.26M | (m) | 1.11× |
| 2014-06-30 | $701.71M | $600.35M | $305.05M | (m) | $168.64M | $145.40M | $41.42M | (m) | 1.17× |
| 2014-03-31 | $683.17M | $517.17M | $286.20M | (m) | $179.92M | $141.13M | $42.79M | (m) | 1.32× |
| 2013-12-31 | $652.71M | $478.35M | $279.06M | (m) | $158.04M | $133.43M | $29.94M | (m) | 1.36× |
| 2013-09-30 | $625.22M | $592.95M | $264.81M | (m) | $151.57M | $145.99M | $38.13M | (m) | 1.05× |
| 2013-06-30 | $614.90M | $551.67M | $251.01M | (m) | $159.12M | $140.94M | $37.58M | (m) | 1.11× |
| 2013-03-31 | $594.39M | $439.58M | $228.36M | (m) | $158.99M | $148.24M | $38.72M | (m) | 1.35× |
| 2012-12-31 | $569.54M | $406.33M | $223.99M | (m) | $138.32M | $140.95M | $35.29M | (m) | 1.40× |
| 2012-09-30 | $570.77M | $415.85M | $221.44M | (m) | $141.37M | $147.47M | $31.73M | (m) | 1.37× |
| 2012-06-30 | $555.31M | $419.15M | $201.81M | (m) | $147.16M | $143.70M | $29.71M | (m) | 1.32× |
| 2012-03-31 | $544.87M | $437.28M | $185.49M | (m) | $160.98M | $141.10M | $40.61M | (m) | 1.25× |
| 2011-12-31 | $524.23M | $436.88M | $183.90M | (m) | $141.28M | $133.10M | $36.55M | (m) | 1.20× |
| 2011-09-30 | $510.75M | $336.37M | $181.50M | (m) | $134.92M | $137.14M | $31.03M | (m) | 1.52× |
| 2011-06-30 | $493.57M | $298.14M | $159.40M | (m) | $149.31M | $133.93M | $29.89M | (m) | 1.66× |
| 2011-03-31 | $465.44M | $272.57M | $153.46M | (m) | $137.55M | $127.05M | $23.33M | (m) | 1.71× |
| 2010-12-31 | $460.59M | $285.11M | $156.91M | (m) | $120.08M | $127.89M | $22.67M | (m) | 1.62× |
| 2010-09-30 | $429.91M | $270.93M | $133.51M | (m) | $120.45M | $131.56M | $25.27M | (m) | 1.59× |
| 2010-06-30 | $410.55M | $271.20M | $117.97M | (m) | $127.14M | $122.03M | $23.19M | (m) | 1.51× |
| 2009-12-31 | $376.34M | $256.31M | $106.73M | (m) | $115.11M | $110.42M | $19.13M | (m) | 1.47× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |